Healthy subject
Conditions
Interventions
Intake of test supplement 1-Intake of test supplement 3-Intake of test supplement 2
Intake of test supplement 2-Intake of test supplement 1-Intake of test supplement 3
Intake of test supplement 3-Inta
Sponsors
FANCL Research Institute, FANCL Corporation
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Japanese males between the ages of 20 and 45 years old at the time of informed consent
Exclusion criteria
Exclusion criteria: 1) Subjects with a history of or undergoing treatment for a serious disease 2) Subjects with a history of, or undergoing treatment for, diseases that affect digestion and absorption 3) Subjects with a history of gastrointestinal resection surgery, excluding appendicectomy 4) Subjects who may have allergies related to the test food ( e.g., shrimp and crab allergies) 5) Subjects who regularly consume food containing ampelopsin 6) Subjects who have difficulty in taking blood samples 7) Persons who are judged by principal investigator or the person in charge to be unsuitable as subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under curve of blood ampelopsin | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood ampelopsin concentration, blood ampelopsin concentration Cmax and Tmax at each time point after ingestion of the test food | — |
Countries
Japan
Contacts
Public ContactYoshiki Shimizu
FANCL Corporation FANCL Research Institute
Outcome results
None listed